Sorlandet Sykehus HF — Clinical Trial Site

41 Registered trials

23 Currently recruiting

Organisation

Sorlandet Sykehus HF

Location

Kristiansand S, Norway

Identifier

ORG-100043027

Address

Sykehusveien 1, 4838, Norway

Departments

...
4406: Hjertemedisinsk avdeling
Cardiology
Center for cancer treatment SSHF, Egsveien 100, Kristiansand
Departement of Neurology
Department of Cardiology
Department of Gynecology / Obstetrics
Department of Hematology
Department of Medicine
Department of Neurology
Department of obstetrics and gynaecology
Department of Obstetrics and Gynecology
Department of Oncology
Department of Opthalmology
Department of Pulmonology
Hematologisk avdeling
Hematology
Hjerteseksjonen
Kvinneklinikken
N/A
Neurology
Oncology
Oncology Department
Øre-nese-hals avdelingen
Research department
Rheumatology
Senter for kreftbehandling
Sorlandet Hospital
Sorlandet Sykehus HF
Sørlandet hospital-Arendal
Sørlandet hospital-Kristiansand
Sørlandet Hospital, Kristiansand
Stroke

Clinical trials at this site (41)

Search interface

IVIGSeN Pending

2022-501717-31-00 Idiopathic painful small fiber neuropathy or sensory ne 10
Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET) Pending

2025-521330-29-00 Major Depression Disorder (MDD) 4
Study to assess the efficacy and safety of Rina-S plus standard of care compared to standard of care for maintenance treatment of participan… Pending

2025-522167-15-00 Ovarian Cancer Platinum-Sensitive Ovarian Cancer (PSOC) 5
A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis (KATALYST-AV) Pending

2025-522176-86-01 Moderate Calcific Aortic Valve Stenosis (CAVS) 5
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting

2023-508047-40-00 Ovarian cancer 5 2026-04-30
Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-… Recruiting

2024-511346-39-00 Behçet’s Syndrome 3 2025-03-28
Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Recruiting

2023-504231-41-01 Locally advanced or metastatic urothelial cancer 4 2024-10-02
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 10 2026-03-26
A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in par… Recruiting

2024-513927-18-00 Amyotrophic Lateral Sclerosis 4 2026-02-16
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esoph… Recruiting

2023-509630-19-00 Esophageal Squamous Cell Carcinoma (ESCC) 5 2025-07-31
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17
Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri… Recruiting

2023-505573-32-00 Immune Thrombocytopenia (ITP) 5 2025-07-01
The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr… Recruiting

2024-517981-40-00 Chronic Migraine 5 2025-06-06
Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting

2024-513779-42-02 Cancer 4 2025-03-27
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl… Recruiting

2023-506998-35-00 Glioblastoma 5 2025-01-08
Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting

2023-509994-22-00 cutaneous malignant melanoma 5 2024-11-15
Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting

2023-507692-21-00 Antiphospholipid syndrome 3 2024-08-22
Prospective comparison of sirolimus against corticosteroids in treatment of patients with active thyroid eye disease Recruiting

2023-510166-27-01 Thyroid eye disease 5 2024-06-22
The CORTAD study Recruiting

2024-512888-31-00 Primary adrenal insufficiency (PAI) 11 2023-08-03
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting

2022-500587-35-01 Stroke 5 2023-07-06
Efficacy of Hyperbaric oxygen in addition to standard treatment for acute sudden deafness Recruiting

2024-510798-84-00 Idiopathic sudden sensorineural hearing loss (ISSNHL) 10 2022-01-28
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Cancer 4 2021-04-01